论文部分内容阅读
目的探讨注射型唑来膦酸治疗原发性骨质疏松症的临床护理。方法将120例原发性骨质疏松症患者列为研究对象,采用数字随机法分为观察组与对照组各60例,均采用注射型唑来膦酸治疗。给予对照组患者常规护理;给予观察组患者健康教育护理,观察两组患者治疗结果,对比两组护理后焦虑程度及对疾病的不确定感。结果所有患者经注射型唑来膦酸治疗后病情均得到有效控制,总有效率达98.3%;护理后焦虑程度评分与疾病不确定感评分分别为(39.71±4.41)分、(41.64±6.54)分,与对照组相比,差异有统计学意义(P<0.05)。结论采用唑来膦酸对原发性骨质疏松症患者行静脉注射治疗后,采用健康教育护理方法,对降低患者焦虑程度与对疾病的不确定感可起到较好的效果。
Objective To investigate the clinical nursing of injecting zoledronic acid in the treatment of primary osteoporosis. Methods A total of 120 patients with primary osteoporosis were enrolled in this study. The patients were divided into observation group and control group (n = 60) by digital randomization method. All patients were treated with zoledronic acid injection. The patients in the control group were given routine nursing care. The patients in the observation group were given health education and nursing care. The treatment outcome of the two groups was observed. The anxiety level and the uncertainty about the disease were compared between the two groups. Results All patients were effectively treated with zoledronic acid injection, with a total effective rate of 98.3%. The scores of anxiety and disease uncertainty after nursing were (39.71 ± 4.41) and (41.64 ± 6.54) Points, compared with the control group, the difference was statistically significant (P <0.05). Conclusion Zoledronic acid treatment of patients with primary osteoporosis after intravenous injection, the use of health education and care methods, to reduce anxiety in patients with the degree of uncertainty of the disease can play a good effect.